All lobbying filings

INVARIANT LLC

Lobbying for SK AMERICAS, INC. · Semiconductors, Energy, Life Sciences

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$140,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 2

SEAN SWEENEY New on this filing

Previously held: U.S. Department of Commerce, CHIPS Program Office: Dep Dir of Leg Affairs (2024-2025); Leg Affairs Adv (2024); Sen. Mark Warner: Leg Asst (2021-2024); Leg Correspondent (2015-2018); State Scheduler (2015)
KENNETH BARBIC New on this filing

Previously held: Asst Secretary for Congressional Relations, USDA (18-21); Dep Asst U.S. Trade Representative for Congressional Affairs, USTR (07-09); House Ways and Means Comm., Subcommittee on Trade: Leg. Asst (06-07); Sr Staff Asst (05-06); Staff Asst (05-06)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 5

Energy/Nuclear

Educate policymakers on electric vehicles and monitor legislative proposals. Discuss implementation issues related to clean energy and energy tax provisions in P.L. 119-21, the One Big Beautiful Bill Act.

Environment/Superfund

Discuss SK as a resource on environmental issues. Monitor implementation issues related to clean energy, electric vehicles, and energy tax provisions in P.L. 119-21, the One Big Beautiful Bill Act.

Science/Technology

Monitor proposals and issues related to semiconductors and artificial intelligence (AI). Monitor implementation issues related to P.L. 119-21, the One Big Beautiful Bill Act.

Pharmacy

Monitor proposals and issues related to biopharmaceuticals. Educate policymakers on SK's active pharmaceutical ingredient manufacturing capabilities.

Taxation/Internal Revenue Code

Monitor developments and issues related to tax and trade. Monitor implementation issues related to tax provisions in P.L. 119-21, the One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.